Amphoraxe Life Sciences Inc.

R&D biotechnology company working on rapid development of antimicrobial peptides (AMPs)

[Amphoraxe Life Sciences Inc. @amphoraxe]

Learn more about the antimicrobial peptides we're developing as replacements for antibiotics, in this short video we prepared as part of the @creativedlab program in which we're participating https://t.co/tosoVTffs8 #amr #antimicrobialresistance

[The Lancet @TheLancet]

NEW—An estimated 1.2 million people died in 2019 from antibiotic-resistant bacterial infections, more deaths than HIV/AIDS or malaria.

#GRAMPaper reveals the scale of antimicrobial resistance (#AMR), now a leading cause of death worldwide: https://t.co/2h5UEKemEq #AMRSOS

[Amphoraxe Life Sciences Inc. @amphoraxe]

A little preview of the presentation our CSO @InancBirol will be giving as part of the Poultry Tech Webinar Series! | Could antimicrobial peptides replace poultry antibiotics? https://t.co/EsV043e4iS

[Amphoraxe Life Sciences Inc. @amphoraxe]

'Another solution that has been suggested is to develop animal-only antibiotics. Timothy Walsh [...] said it was “bonkers to use the same drugs in animal feeds as you would to treat neonatal sepsis”' - we couldn't agree more!

https://t.co/7UryWehFMN

[Amphoraxe Life Sciences Inc. @amphoraxe]

“If you want to eliminate the worst types of salmonella, you really do have to start at the farm because that’s where the pathogens are spreading between animals”: Sarah Sorscher, Center for Science in the Public Interest https://t.co/etwiuMauzs

[Global Antibiotic R&D Partnership (GARDP) @gardp_amr]

“If we don’t fix this now, then we’re going to face this again in #AMR, and every other health issue that follows.” - Article summary from @HealthPolicyW on recent webinar with GARDP's Executive Director @Manica_amr & @GHC_IHEID 👉https://t.co/yFCv1BQU1S

[Amphoraxe Life Sciences Inc. @amphoraxe]

Thank you @lifesciences_bc for including us in the inaugural cohort of the Investor Readiness Program! We can highly recommend this excellent initiative to other ventures.

[Pew Health @pewhealth]

[THREAD] Our annual assessment of the #antibiotic pipeline is here.

One thing is clear: There are still too few drugs in development to meet current and anticipated patient needs. https://t.co/qrhlfLqPGd 👇

[Amphoraxe Life Sciences Inc. @amphoraxe]

Really looking forward to this one

[Global Antibiotic R&D Partnership (GARDP) @gardp_amr]

This Thursday March 4, @gardp_amr will host a free webinar to discuss how we can apply the lessons learned from #COVID-19 to tackle drug resistance and ensure access to appropriate #antibiotics. Be sure to register and share with your networks: https://t.co/OGckpqP4ji

[Uppsala Antibiotic Center @UAC_UU]

New episode! 🎧 #theAMRstudio brings you philosophy and bioethics within #AntibioticResistance thanks to @AncillottiMirko! Tune in to learn about his background and work
In the news: why does resistance to antibiotics and vaccines evolve differently?
⬇️
https://t.co/e85LQVCIi7

[Amphoraxe Life Sciences Inc. @amphoraxe]

Broken Antibiotics Market Puts Cancer Treatments at Risk https://t.co/xnrUM7RXTy via @pewtrusts

[Amphoraxe Life Sciences Inc. @amphoraxe]

"Reining in the inappropriate use of antibiotics, in humans and in farmed animals, is key to staying ahead of AMR, but we also need novel anti-infectives coming down the pipeline – new last resorts". #AMR https://t.co/A9DVVLKqAS

[Global Antibiotic R&D Partnership (GARDP) @gardp_amr]

Join us for our upcoming webinar.

4 March | 4-5:30pm CET

How can we apply the lessons learned from #COVID-19 to tackle drug resistance and ensure access to appropriate #antibiotics?

👉Registration is open: https://t.co/CEbDR1i8Al👈

[Amphoraxe Life Sciences Inc. @amphoraxe]

We're included in this article about how @ubcentrepreneur is helping startup R&D ventures make progress despite the COVID-19 pandemic. We're looking forward to being able to meet everyone from our new virtual network in person soon!

[Innovation UBC @innovationubc]

Venture creation through commercialization has never been more important than it is today. Find out how these 3 research based ventures showed resilience in the face of a global pandemic in our most recent post, here:

https://t.co/T2cyeO8dc9

#UBCentrepreneur #Lab2Launch

[Amphoraxe Life Sciences Inc. @amphoraxe]

hat tip to @UAC_UU for highlighting this new review on the latest episode of their excellent #theAMRstudio podcast! https://t.co/0DgRB7QtvF

[Amphoraxe Life Sciences Inc. @amphoraxe]

Traditional volume-based sales revenues don't work for antimicrobial drugs whose use needs to be restricted to help prevent the emergence of #antimicrobialresistance. A new paper analyses some new reimbursement models that could solve this problem https://t.co/4JrRNpdFtW #AMR

[Amphoraxe Life Sciences Inc. @amphoraxe]

Antibiotic Sales for Use in Food Animals Increased Again in 2019 https://t.co/GfpKm5CnDl via @pewtrusts

[Amphoraxe Life Sciences Inc. @amphoraxe]

We are delighted to welcome Dr. Mert Demiray to Amphoraxe as our Business Financing Adviser! You can read more about Mert and the rest of our management team on our website: https://t.co/AIe0dACIDr

[Innovation UBC @innovationubc]

#VS2020: These are just some of the incredible entrepreneurs you'll be hearing from today at our Sneak-a-Peeks section, happening NOW! ✨

[Amphoraxe Life Sciences Inc. @amphoraxe]

We're going to be in great company @ubcentrepreneur 's 2020 Venture Showcase! Hope to see you there

[Innovation UBC @innovationubc]

Just when you think it can't get any better...we are thrilled to share the second set of ventures joining us for our 2020 Venture Showcase! 🎉

Have you RSVP'd? Meet the other ventures presenting and RSVP here https://t.co/1O1NoPuz2S

#UBCentrepreneur #VS2020

[Amphoraxe Life Sciences Inc. @amphoraxe]

"If Scientists Don't Develop New Antibiotics Soon, 'We'll All Be in a Lot of Trouble'" - Q&A with @CARB_X 's chief of research and development, Erin Duffy https://t.co/WucFHafBaV via @pewhealth #amr